Unknown

Dataset Information

0

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.


ABSTRACT: Genomic profiling studies suggest that triple-negative breast cancer (TNBC) is a heterogeneous disease. In this study, we sought to define TNBC subtypes and identify subtype-specific markers and targets.RNA and DNA profiling analyses were conducted on 198 TNBC tumors [estrogen receptor (ER) negativity defined as Allred scale value ? 2] with >50% cellularity (discovery set: n = 84; validation set: n = 114) collected at Baylor College of Medicine (Houston, TX). An external dataset of seven publically accessible TNBC studies was used to confirm results. DNA copy number, disease-free survival (DFS), and disease-specific survival (DSS) were analyzed independently using these datasets.We identified and confirmed four distinct TNBC subtypes: (i) luminal androgen receptor (AR; LAR), (ii) mesenchymal (MES), (iii) basal-like immunosuppressed (BLIS), and (iv) basal-like immune-activated (BLIA). Of these, prognosis is worst for BLIS tumors and best for BLIA tumors for both DFS (log-rank test: P = 0.042 and 0.041, respectively) and DSS (log-rank test: P = 0.039 and 0.029, respectively). DNA copy number analysis produced two major groups (LAR and MES/BLIS/BLIA) and suggested that gene amplification drives gene expression in some cases [FGFR2 (BLIS)]. Putative subtype-specific targets were identified: (i) LAR: androgen receptor and the cell surface mucin MUC1, (ii) MES: growth factor receptors [platelet-derived growth factor (PDGF) receptor A; c-Kit], (iii) BLIS: an immunosuppressing molecule (VTCN1), and (iv) BLIA: Stat signal transduction molecules and cytokines.There are four stable TNBC subtypes characterized by the expression of distinct molecular profiles that have distinct prognoses. These studies identify novel subtype-specific targets that can be targeted in the future for the effective treatment of TNBCs.

SUBMITTER: Burstein MD 

PROVIDER: S-EPMC4362882 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.

Burstein Matthew D MD   Tsimelzon Anna A   Poage Graham M GM   Covington Kyle R KR   Contreras Alejandro A   Fuqua Suzanne A W SA   Savage Michelle I MI   Osborne C Kent CK   Hilsenbeck Susan G SG   Chang Jenny C JC   Mills Gordon B GB   Lau Ching C CC   Brown Powel H PH  

Clinical cancer research : an official journal of the American Association for Cancer Research 20140910 7


<h4>Purpose</h4>Genomic profiling studies suggest that triple-negative breast cancer (TNBC) is a heterogeneous disease. In this study, we sought to define TNBC subtypes and identify subtype-specific markers and targets.<h4>Experimental design</h4>RNA and DNA profiling analyses were conducted on 198 TNBC tumors [estrogen receptor (ER) negativity defined as Allred scale value ≤ 2] with >50% cellularity (discovery set: n = 84; validation set: n = 114) collected at Baylor College of Medicine (Housto  ...[more]

Similar Datasets

2015-12-23 | E-GEOD-76275 | biostudies-arrayexpress
2015-12-23 | GSE76275 | GEO
2015-12-23 | GSE76274 | GEO
2015-12-18 | E-GEOD-76124 | biostudies-arrayexpress
2015-12-18 | GSE76124 | GEO
| PRJNA306766 | ENA
| S-EPMC8560912 | biostudies-literature
2020-05-20 | GSE150814 | GEO